Breakthrough in Neonatal Diabetes Research
International scientists have identified a previously unknown genetic driver behind a rare form of diabetes that exclusively affects newborn infants, according to recent research reports. The study reveals that specific mutations in the TMEM167A gene can disable and ultimately destroy insulin-producing cells, providing crucial insights into both rare and common forms of diabetes.
Understanding MEDS Syndrome
The research focused on six babies diagnosed with neonatal diabetes and microcephaly before six months of age, with five also experiencing epilepsy. This combination of conditions, known as MEDS (microcephaly, epilepsy, and diabetes syndrome), is extremely rare with only 11 documented cases worldwide. The report states that before this study, only two genes had been linked to the syndrome, but genome sequencing revealed TMEM167A as the third genetic cause.
Sources indicate that for a baby to develop MEDS, they must inherit two mutated copies of the responsible gene—one from each parent. This inheritance pattern applies to the newly identified TMEM167A variant, which researchers found disrupts normal insulin secretion while simultaneously affecting neurological function.
Mechanisms of Insulin Disruption
To understand how the gene variant causes diabetes, researchers used stem cell technology to recreate the condition in laboratory settings. According to their published methodology, they removed the normal TMEM167A gene from human pluripotent stem cells and replaced it with the variant from a MEDS patient. These cells were then developed into beta cells, which normally produce insulin in the pancreas.
The findings, detailed in their journal publication, showed that while the gene variant didn’t prevent beta cell development, it rendered them non-functional. When exposed to glucose, these modified beta cells failed to release insulin as healthy cells would. Additionally, the cells experienced severe stress in their endoplasmic reticulum—the internal cellular transport system—often leading to cell death.
Cross-Organ Implications
Analysts suggest the discovery explains why affected infants experience both metabolic and neurological symptoms. The TMEM167A gene is active in both the pancreas and brain across species, indicating its fundamental role in both insulin production and neuron function. “The ability to generate insulin-producing cells from stem cells has enabled us to study what is dysfunctional in the beta cells of patients with rare forms as well as other types of diabetes,” says diabetologist Miriam Cnop from Free University of Brussels in Belgium, who was involved in the research.
Research Implications and Future Directions
University of Exeter molecular geneticist Elisa de Franco, whose institution reported on the findings, explained the significance: “Finding the DNA changes that cause diabetes in babies gives us a unique way to find the genes that play key roles in making and secreting insulin. The finding of specific DNA changes causing this rare type of diabetes in six children led us to clarifying the function of a little-known gene, TMEM167A, showing how it plays a key role in insulin secretion.”
The research team emphasizes that this discovery not only helps families affected by MEDS syndrome but also contributes to broader understanding of diabetes mechanisms. Meanwhile, industry developments in medical technology continue to advance research capabilities. Similar progress in recent technology has enabled more sophisticated genetic analysis, while related innovations in data processing support complex medical research. These market trends collectively enhance our ability to understand and treat rare genetic disorders.
This research represents a significant step toward personalized treatments for rare genetic forms of diabetes and demonstrates how studying extreme cases can illuminate broader biological mechanisms relevant to more common diseases.
This article aggregates information from publicly available sources. All trademarks and copyrights belong to their respective owners.
Note: Featured image is for illustrative purposes only and does not represent any specific product, service, or entity mentioned in this article.
